Oncology Clinical Trials in Baltimore, MD

As of July 2026, 283 paid clinical trials are recruiting for Oncology in Baltimore, Maryland. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 16, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

283 clinical trials for Oncology

·Clear filters·↓ Download CSV

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

for Multiple Myeloma

Drug: Teclistamab

42 locations incl. Phoenix

Sponsor: European Myeloma Network B.V.

Sex: All·Age: 18+

Code: NCT05243797·Phase 3·Recruiting

Apply to this trial

Collection of Tissue Samples for Cancer Research

for Neoplasms

16 locations incl. Atlanta

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 2 Months+

Code: NCT00900198·Recruiting

Apply to this trial

Abatacept in Immune Checkpoint Inhibitor Myocarditis

for Myocarditis Acute

29 locations incl. Los Angeles

Sponsor: Massachusetts General Hospital

Sex: All·Age: 18+

Code: NCT05335928·Phase 3·Recruiting

Apply to this trial

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

for Gastric Adenocarcinoma

55 locations incl. Irvine

Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All·Age: 18+

Code: NCT07001748·Phase 2, Phase 3·Recruiting

Apply to this trial

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

for Anatomic Stage IV Breast Cancer AJCC v8

58 locations incl. Phoenix

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT06500481·Phase 3·Recruiting

Apply to this trial

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

for Prostate Cancer

48 locations incl. Tuscaloosa

Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male·Age: 21+

Code: NCT03151629·Recruiting

Apply to this trial

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

for Barretts Esophagus With Dysplasia

23 locations incl. Los Angeles

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 89

Code: NCT05753748·Recruiting

Apply to this trial

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

for Hodgkin Lymphoma in Remission

69 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: All ages

Code: NCT01790152·Recruiting

Apply to this trial

Clinical Trial of Approaches to Prostate Cancer Surgery

for Prostate Cancer

9 locations incl. Duarte

Sponsor: Weill Medical College of Cornell University

Sex: Male·Age: 40 - 80

Code: NCT05155501·Recruiting

Apply to this trial

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

for HER2-negative Breast Cancer

7 locations incl. Chicago

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18 - 99

Code: NCT05029999·Phase 1·Recruiting

Apply to this trial

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

for Recurrent World Health Organization (WHO) Grade II Glioma

Drug: Trametinib

17 locations incl. Birmingham

Sponsor: University of California, San Francisco

Sex: All·Age: 1 - 25

Code: NCT04485559·Phase 1·Recruiting

Apply to this trial

Registry Study for Radiation Therapy Outcomes

for Neoplasms

29 locations incl. Scottsdale

Sponsor: Proton Collaborative Group

Sex: All·Age: All ages

Code: NCT01255748·Recruiting

Apply to this trial

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

for Acute Myeloid Leukemia

22 locations incl. New Haven

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06484062·Phase 1·Recruiting

Apply to this trial

A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung Cancer

for Non-Small Cell Lung Cancer

4 locations incl. Baltimore

Sponsor: University of Maryland, Baltimore

Sex: All·Age: 18+

Code: NCT06800339·Phase 1·Recruiting

Apply to this trial

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

for Pancreatic Cancer

11 locations incl. Birmingham

Sponsor: University of Louisville

Sex: All·Age: 18+

Code: NCT02674100·Recruiting

Apply to this trial

Virtual Reality Therapy for Cancer-Treatment Associated Symptoms

for Cancer

2 locations incl. Baltimore

Sponsor: University of Maryland, Baltimore

Sex: All·Age: 18 - 88

Code: NCT06248216·Recruiting

Apply to this trial

Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue

for Neoplasms

1 location in Baltimore

Sponsor: University of Maryland, Baltimore

Sex: All·Age: 18+

Code: NCT06482515·Phase 2·Recruiting

Apply to this trial

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

for Acute Myeloid Leukemia

22 locations incl. Orange

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 75

Code: NCT05886049·Phase 1·Recruiting

Apply to this trial

Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer

for Biliary Tract Cancer

2 locations incl. Baltimore

Sponsor: University of Maryland, Baltimore

Sex: All·Age: 21+

Code: NCT06546969·Phase 1·Recruiting

Apply to this trial

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

for Breast Cancer

9 locations incl. Scottsdale

Sponsor: Proton Collaborative Group

Sex: Female·Age: 19+

Code: NCT05856773·Phase 3·Recruiting

Apply to this trial

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

for Hematopoietic and Lymphoid Cell Neoplasm

29 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: 2 - 18

Code: NCT05711667·Phase 3·Recruiting

Apply to this trial

TERPS Trial for de Novo Oligometastic Prostate Cancer

for Prostate Cancer

10 locations incl. La Jolla

Sponsor: University of Maryland, Baltimore

Sex: Male·Age: 18+

Code: NCT05223803·Phase 2·Recruiting

Apply to this trial

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

for Relapsed or Refractory Acute Myeloid Leukemia (AML)

26 locations incl. Charleston

Sponsor: Institut de Recherches Internationales Servier

Sex: All·Age: 18+

Code: NCT02074839·Phase 1·Recruiting

Apply to this trial

LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

for Glioma

5 locations incl. Baltimore

Sponsor: University of Maryland, Baltimore

Sex: All·Age: 18+

Code: NCT04699773·Recruiting

Apply to this trial

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

for Prostate Cancer

20 locations incl. Long Beach

Sponsor: VA Office of Research and Development

Sex: Male·Age: 18+

Code: NCT04787744·Phase 2, Phase 3·Recruiting

Apply to this trial

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

for Anatomic Stage IV Breast Cancer AJCC v8

Drug: Tremelimumab

30 locations incl. Aurora

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT03606967·Phase 2·Recruiting

Apply to this trial

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

for Autoimmune Disease

Drug: Nivolumab

51 locations incl. Sacramento

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT03816345·Phase 1·Recruiting

Apply to this trial

JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

for Non-Small Cell Lung Cancer

40 locations incl. Savannah

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18+

Code: NCT02468024·Phase 3·Recruiting

Apply to this trial

Measuring Surgical Recovery After Radical Cystectomy

for Bladder Cancer

11 locations incl. San Francisco

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT03193970·Recruiting

Apply to this trial

Vaginal Cuff Brachytherapy Fractionation Study

for Endometrial Cancer

3 locations incl. Baltimore

Sponsor: Kara Romano, MD

Sex: Female·Age: 18+

Code: NCT03785288·Phase 3·Recruiting

Apply to this trial

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)

for Head and Neck Cancer

5 locations incl. Baltimore

Sponsor: University of Maryland, Baltimore

Sex: All·Age: 18+

Code: NCT06088381·Phase 2·Recruiting

Apply to this trial

LITT Followed by Hypofractionated RT for Recurrent Gliomas

for Glioblastoma

4 locations incl. Baltimore

Sponsor: University of Maryland, Baltimore

Sex: All·Age: 22+

Code: NCT04181684·Recruiting

Apply to this trial

Excision of Lymph Node Trial (EXCILYNT) (Mel69)

for Melanoma

7 locations incl. Atlanta

Sponsor: Craig L Slingluff, Jr

Sex: All·Age: 18+

Code: NCT05839912·Recruiting

Apply to this trial

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

for Breast Cancer

9 locations incl. Scottsdale

Sponsor: Proton Collaborative Group

Sex: Female·Age: 50+

Code: NCT01766297·Phase 2·Recruiting

Apply to this trial

REmote Symptom COllection to improVE postopeRative Care

for Gastrointestinal Cancer

2 locations incl. Baltimore

Sponsor: Medstar Health Research Institute

Sex: All·Age: 18+

Code: NCT06190730·Recruiting

Apply to this trial

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

for Hematologic Malignancy

29 locations incl. Los Angeles

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium

Sex: All·Age: 1 - 21

Code: NCT05476770·Phase 1·Recruiting

Apply to this trial

Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer

for Colorectal Cancer

Drug: Cemiplimab

1 location in Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All·Age: 18+

Code: NCT07281768·Phase 2·Recruiting

Apply to this trial

DK222 Study at Hopkins

for Non-Small Cell Lung Cancer

1 location in Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All·Age: 18+

Code: NCT07140315·Phase 1·Recruiting

Apply to this trial

Precision Radiotherapy Enabled by Molecular MRI

for Brain Cancer

1 location in Baltimore

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All·Age: 18+

Code: NCT07512154·Recruiting

Apply to this trial

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

6 locations incl. San Francisco

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland

Sex: All·Age: 18+

Code: NCT07223814·Phase 3·Recruiting

Apply to this trial

Conditions in Oncology (Baltimore, MD)

Non-small cell lung cancer (NSCLC)· 45 Solid tumor· 38 Breast cancer· 31 Prostate cancer· 23 Pancreatic cancer· 19 Cancer (any)· 18 Colorectal cancer· 16 Acute myeloid leukemia (AML)· 16 Head and neck cancer· 14 Bladder cancer· 13 Metastatic prostate cancer· 12 Ovarian cancer· 11 Myelodysplastic syndromes (MDS)· 11 Hematologic malignancy· 11 Multiple myeloma· 10 Metastatic breast cancer· 9 Endometrial cancer· 8 Glioblastoma· 8 Non-Hodgkin lymphoma· 8 Lung cancer· 7 Melanoma· 7 Kidney cancer· 6 Chronic lymphocytic leukemia (CLL)· 6 Leukemia (other)· 6 Cervical cancer· 5 Glioma· 5 Brain cancer· 5 Diffuse large B-cell lymphoma (DLBCL)· 5 Follicular lymphoma· 5 Mantle cell lymphoma· 5 Small lymphocytic lymphoma· 5 Triple-negative breast cancer· 4 Gastric cancer· 4 Esophageal cancer· 4 Biliary tract cancer· 4 Myelofibrosis· 4 Sarcoma· 4 Small cell lung cancer· 3 Gastroesophageal junction cancer· 3 Liver cancer· 3 Gastrointestinal cancer· 3 Fallopian tube cancer· 3 Chronic myelomonocytic leukemia· 3 Hodgkin lymphoma· 3 Marginal zone lymphoma· 3 Osteosarcoma· 3 HER2-negative breast cancer· 2 Acute lymphoblastic leukemia· 2 Myeloproliferative neoplasm· 2 Ewing sarcoma· 2 Neuroblastoma· 2 Metastatic colorectal cancer· 1 Colon cancer· 1 Rectal cancer· 1 Uterine cancer· 1 Brain metastases· 1 Skin cancer· 1 Thyroid cancer· 1 Soft tissue sarcoma· 1 Rhabdomyosarcoma· 1 Mesothelioma· 1 Neuroendocrine tumors· 1